High Quality Content by WIKIPEDIA articles! Anavex Life Sciences Corp. is a biopharmaceutical company engaged in the discovery and development of new drugs for the treatment of central nervous system (CNS) diseases and different types of cancer, utilizing its proprietary SIGMACEPTOR™ Discovery Platform. The Anavex portfolio involves sigma receptor ligand compounds in the preclinical stage that target neurodegenerative diseases and cancer. According to a number of recent studies, these ligands have the ability to target certain CNS conditions, such as depression and Alzheimer’s disease, as well as certain types of cancer, through agonism or antagonism of sigma receptors

Данное издание не является оригинальным. Книга печатается по технологии принт-он-деманд после получения заказа.